Literature DB >> 548019

The inhibition of malignant cell growth by ketone bodies.

B A Magee, N Potezny, A M Rofe, R A Conyers.   

Abstract

The effect of ketone bodies on the growth, in culture, of transformed lymphoblasts (Raji cells) was investigated. Cell growth was inhibited and this effect was reversible, non-toxic, and proportional to the concentration of D-beta-hydroxybutyrate up to 20mM. The total glucose utilisation and the total lactate production were reduced in proportion to the inhibition of cell proliferation. D-beta-hydroxybutyrate was not metabolised by the cells. Other glycolytic inhibitors and chemical analogues of D-beta-hydroxybutyrate either did not inhibit or proved to be too toxic for cell growth. D-beta-hydroxybutyrate also inhibited the growth of rabbit kidney (RK13), HeLa, mouse melanoma (B16), fibroblast and trypsin-dispersed human thyroid and beef testis cells. Moreover, in vivo dietary-induced ketosis reduced the number of B16 melanoma deposits in the lungs of C57BL/6 mice by two-thirds. The significance of these results in the clinical management of cancer cachexia is discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 548019     DOI: 10.1038/icb.1979.54

Source DB:  PubMed          Journal:  Aust J Exp Biol Med Sci        ISSN: 0004-945X


  40 in total

1.  A low carbohydrate, high protein diet combined with celecoxib markedly reduces metastasis.

Authors:  Victor W Ho; Melisa J Hamilton; Ngoc-Ha Thi Dang; Brian E Hsu; Hans H Adomat; Emma S Guns; Aalim Weljie; Ismael Samudio; Kevin L Bennewith; Gerald Krystal
Journal:  Carcinogenesis       Date:  2014-07-14       Impact factor: 4.944

2.  Changes in cerebral metabolism during ketogenic diet in patients with primary brain tumors: 1H-MRS study.

Authors:  Moran Artzi; Gilad Liberman; Nachum Vaisman; Felix Bokstein; Faina Vitinshtein; Orna Aizenstein; Dafna Ben Bashat
Journal:  J Neurooncol       Date:  2017-01-10       Impact factor: 4.130

Review 3.  The ketogenic diet for the treatment of malignant glioma.

Authors:  Eric C Woolf; Adrienne C Scheck
Journal:  J Lipid Res       Date:  2014-02-06       Impact factor: 5.922

Review 4.  Targeting the Warburg effect for cancer treatment: Ketogenic diets for management of glioma.

Authors:  Angela Poff; Andrew P Koutnik; Kathleen M Egan; Solmaz Sahebjam; Dominic D'Agostino; Nagi B Kumar
Journal:  Semin Cancer Biol       Date:  2017-12-30       Impact factor: 15.707

5.  Ketone-body metabolism after surgical stress or partial hepatectomy. Evidence for decreased ketogenesis and a site of control distal to carnitine palmitoyltransferase I.

Authors:  P S Schofield; T J French; M C Sugden
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

6.  The effects of recombinant tumour necrosis factor (cachectin) on metabolism in isolated rat adipocyte, hepatocyte and muscle preparations.

Authors:  A M Rofe; R A Conyers; R Bais; J R Gamble; M A Vadas
Journal:  Biochem J       Date:  1987-11-01       Impact factor: 3.857

7.  Ketone-body metabolism in tumour-bearing rats.

Authors:  A M Rofe; R Bais; R A Conyers
Journal:  Biochem J       Date:  1986-01-15       Impact factor: 3.857

Review 8.  A framework for examining how diet impacts tumour metabolism.

Authors:  Evan C Lien; Matthew G Vander Heiden
Journal:  Nat Rev Cancer       Date:  2019-09-17       Impact factor: 60.716

9.  The ketogenic diet and hyperbaric oxygen therapy prolong survival in mice with systemic metastatic cancer.

Authors:  Angela M Poff; Csilla Ari; Thomas N Seyfried; Dominic P D'Agostino
Journal:  PLoS One       Date:  2013-06-05       Impact factor: 3.240

10.  Effects of a ketogenic diet on the quality of life in 16 patients with advanced cancer: A pilot trial.

Authors:  Melanie Schmidt; Nadja Pfetzer; Micheal Schwab; Ingrid Strauss; Ulrike Kämmerer
Journal:  Nutr Metab (Lond)       Date:  2011-07-27       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.